ZELLUNA logo ZELLUNA

Selskapsinformasjon

Ticker: ZLNA
Børsverdi: 573 MNOK
Nordnet 3 325
Avanza 636
Kommende hendelserHendelser ℹ️
Rapport: 20.08.2026
07.05.2026 07:00

Zelluna ASA: First Quarter 2026 results

Oslo, 7 May 2026 - Zelluna (OSE: ZLNA), a company pioneering allogeneic "off- the-shelf" T Cell Receptor-based Natural Killer (TCR-NK) cell therapies for the treatment of solid cancers, today presents its results for the first quarter 2026. Webcast scheduled for 7 May 2026 at 08:30 CET. Link to web...

Les hele pressemeldingen

Antall Eiere